Societe des Produits Nestle S.A., 10% Owner at Aimmune Therapeutics, Inc. (AIMT), bought 97,552,870 shares at $34.50 ($3.4B) on 2020-10-13, disclosed to the SEC on 2020-10-15.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $34.50 | 10,681,704 | $368.5M | 10.9% |
| 2 | $34.50 | 43,435,583 | $1.5B | 44.5% |
| 3 | $34.50 | 43,435,583 | $1.5B | 44.5% |
| Total | $34.50 avg | 97,552,870 | $3.4B | 100% |
| Filing → |